Henry Schein, Inc. operates in the healthcare sector, providing essential products and services to a wide range of medical establishments. The company's robust distribution network and innovative technology solutions offer solid growth potential. However, market competition and economic fluctuations present challenges for future performance.
Henry Schein, Inc. currently holds a 'B+' rating in our assessment, reflecting its solid financial standing and potential for growth.
| Category | Score | Visualization |
|---|---|---|
| Discounted Cash Flow | 4 | |
| Return on Equity | 4 | |
| Return on Assets | 4 | |
| Debt to Equity | 1 | |
| Price to Earnings | 2 | |
| Price to Book | 3 |
The historical scores reflect the consistency in the company's financial metrics over time.
| Date | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-07-24 | 3 | 4 | 4 | 4 | 1 | 2 | 3 |
| Previous Date | 0 | 4 | 4 | 4 | 1 | 2 | 3 |
Analyst consensus indicates a positive outlook with potential upside to the current stock price based on projected targets.
| High | Low | Median | Consensus |
|---|---|---|---|
| $86 | $75 | $80.5 | $80.5 |
The sentiment among analysts is largely favorable, with a majority recommending a "Buy".
| Recommendation | Count | Visualization |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 14 | |
| Hold | 13 | |
| Sell | 3 | |
| Strong Sell | 0 |
In conclusion, Henry Schein, Inc. showcases a solid business model underlined by strong fundamentals and promising analyst projections. While the overall market presents volatility, the company's focus on technological advancements and healthcare distribution could provide resilience against competitive pressures. Yet, investors should be mindful of potential macroeconomic impacts. Overall, the stock represents a balanced risk-reward proposition.